Login
Search |
JOURNAL TOOLS |
| Publishing options |
| eTOC |
| To subscribe |
| Submit an article |
| Recommend to your librarian |
ARTICLE TOOLS |
| Publication history |
| Reprints |
| Permissions |
| Cite this article as |
| Share |
YOUR ACCOUNT
YOUR ORDERS
SHOPPING BASKET
Items: 0
Total amount: € 0,00
HOW TO ORDER
YOUR SUBSCRIPTIONS
YOUR ARTICLES
YOUR EBOOKS
COUPON
ACCESSIBILITY
LETTERS TO THE EDITOR
Panminerva Medica 2018 December;60(4):228-30
DOI: 10.23736/S0031-0808.18.03468-7
Copyright © 2018 EDIZIONI MINERVA MEDICA
language: English
Tetrahydrocannabinol: a drug of interest
Juhi TIWARI 1, Kartikey BAJPAI 2, Gaurav GUPTA 1 ✉, Rahul SHARMA 1, Rajesh K. VERMA 1, Kamal DUA 3, 4, 5
1 School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, India; 2 MET IIT College Bandra, Mumbai, India; 3 Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, Australia; 4 School of Biomedical Sciences and Pharmacy, The University of Newcastle, Callaghan, Australia; 5 Priority Research Centre for Healthy Lungs, Hunter Medical Research Institute, Newcastle, Australia
